A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus

Chiara De Waure; Maria Lucia Specchia; A Doria; G Turchetti; Silvio Capizzi; L Iaccarino; F Pierotti; F Kheiraoui; Chiara Cadeddu; I Palla; Francesco Di Nardo; Maria Daniela Gliubizzi; Antonella Sferrazza; N Nicolotti; Gualano; G La Torre; Maria Luisa Di Pietro; Walter Ricciardi

A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus

Chiara De Waure, Maria Lucia Specchia, A Doria, G Turchetti, Silvio Capizzi, L Iaccarino, F Pierotti, F Kheiraoui, Chiara Cadeddu, I Palla, Francesco Di Nardo, Maria Daniela Gliubizzi, Antonella Sferrazza, N Nicolotti, Gualano, G La Torre, Maria Luisa Di Pietro, Walter Ricciardi

Risultato della ricerca: Contributo in libro › Contributo a conferenza

Abstract

Nessuno

Lingua originale	Inglese
Titolo della pubblicazione ospite	Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”
Pagine	131
Numero di pagine	1
Stato di pubblicazione	Pubblicato - 2013
Evento	10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?” - Seoul Durata: 15 giu 2013 → 19 giu 2013

Convegno

Convegno	10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”
Città	Seoul
Periodo	15/6/13 → 19/6/13

Keywords

Belimumab
Health Technology Assessment
Systemic Lupus Erythematosus

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

De Waure, C., Specchia, M. L., Doria, A., Turchetti, G., Capizzi, S., Iaccarino, L., Pierotti, F., Kheiraoui, F., Cadeddu, C., Palla, I., Di Nardo, F., Gliubizzi, M. D., Sferrazza, A., Nicolotti, N., Gualano, La Torre, G., Di Pietro, M. L., & Ricciardi, W. (2013). A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus. In Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?” (pagg. 131)

@inproceedings{2954d4bc7e1b44dc8e892c1f393a2d7d,

title = "A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus",

abstract = "Nessuno",

keywords = "Belimumab, Health Technology Assessment, Systemic Lupus Erythematosus, Belimumab, Health Technology Assessment, Systemic Lupus Erythematosus",

author = "\{De Waure\}, Chiara and Specchia, \{Maria Lucia\} and A Doria and G Turchetti and Silvio Capizzi and L Iaccarino and F Pierotti and F Kheiraoui and Chiara Cadeddu and I Palla and \{Di Nardo\}, Francesco and Gliubizzi, \{Maria Daniela\} and Antonella Sferrazza and N Nicolotti and Gualano and \{La Torre\}, G and \{Di Pietro\}, \{Maria Luisa\} and Walter Ricciardi",

year = "2013",

language = "English",

isbn = "Nessuno",

pages = "131",

booktitle = "Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”",

note = "10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?” ; Conference date: 15-06-2013 Through 19-06-2013",

}

De Waure, C, Specchia, ML, Doria, A, Turchetti, G, Capizzi, S, Iaccarino, L, Pierotti, F, Kheiraoui, F, Cadeddu, C, Palla, I, Di Nardo, F, Gliubizzi, MD, Sferrazza, A, Nicolotti, N, Gualano, La Torre, G, Di Pietro, ML & Ricciardi, W 2013, A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus. in Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”. pagg. 131, 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”, Seoul, 15/6/13.

TY - GEN

T1 - A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus

AU - De Waure, Chiara

AU - Specchia, Maria Lucia

AU - Doria, A

AU - Turchetti, G

AU - Capizzi, Silvio

AU - Iaccarino, L

AU - Pierotti, F

AU - Kheiraoui, F

AU - Cadeddu, Chiara

AU - Palla, I

AU - Di Nardo, Francesco

AU - Gliubizzi, Maria Daniela

AU - Sferrazza, Antonella

AU - Nicolotti, N

AU - Gualano,

AU - La Torre, G

AU - Di Pietro, Maria Luisa

AU - Ricciardi, Walter

PY - 2013

Y1 - 2013

N2 - Nessuno

AB - Nessuno

KW - Belimumab

KW - Health Technology Assessment

KW - Systemic Lupus Erythematosus

KW - Belimumab

KW - Health Technology Assessment

KW - Systemic Lupus Erythematosus

UR - http://hdl.handle.net/10807/51120

M3 - Conference contribution

SN - Nessuno

SP - 131

BT - Proceedings of 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”

T2 - 10th HTAi Annual Meeting “Evidence, Values and Decision Making: Science or Art?”

Y2 - 15 June 2013 through 19 June 2013

ER -

A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus

Abstract

Convegno

Keywords

Altri file e collegamenti

Fingerprint

Cita questo